What/Who: On Monday, January 17 at 7 p.m., Dustin Robinson, Esq. CPA, will present his monthly Psychedelic Series at Soho Beach House Miami. Emceed by Robinson, this Psychedelic Women Panel will highlight the great work of leading females in the psychedelics industry. Moderated by Julie Zukof, wellness brand advisor founder of Psychedelic Women, the panel will feature Denise C. Vidot, PhD, founder of CanaVee, and Michelle Weiner, DO, MPH. To kick off the panel, there will be a transformative psychedelic breathwork session led by Bianca Abbott, co-founder of LunaFast.
Every month, the Psychedelic Series features experts in the psychedelics space from CEOs, doctors, lawyers and celebrities. Past panelists include NBA champion Lamar Odom, Stanley Cup champion Daniel Carcillo, Psilera Bioscience CEO Chris Witowski, PhD, Silo Wellness CEO Douglas K. Gordon, and others.
Wellness strategy guru, researcher and innovator Zukof is the wellness brand advisor founder of Psychedelic Women. Previously working with prestigious agencies, Zukof brings her expertise to consulting both agency partners and brands, and leverages lean teams to partner wellness companies with principal talent. Her unique style is influenced by her distinctive experience in growing companies and diverse cultural travels. Her background has enabled the creation of groundbreaking solutions for start-ups, new products and global Fortune 500 brands. Zukof’s passion for entrepreneurship is acutely represented in consulting small companies who have grown to become leaders. Her creativity combined with her business strategy prowess play key roles in driving her client’s successes.
Dr. Vidot is the founder of CanaVee, a non-profit organization dedicated to providing trailblazing research-based, patient-centered solutions with her community. She is also an epidemiologist and tenured-track assistant professor at the University of Miami School of Nursing and Health Studies where she is the principal investigator of the Cannabis Health and Fitness Laboratory. Dr. Vidot’s research is centered upon physical health outcomes of substance use and abuse across the lifespan among racial/ethnic minority populations. Specifically, she examines cardiovascular and metabolic outcomes among cannabis users from an epidemiological perspective. Dr. Vidot is also interested in the cardiovascular and metabolic health outcomes among HIV patients, and those at risk for HIV, who use cannabis.
Dr. Weiner is double board-certified in interventional pain medicine and physical medicine and rehabilitation. Dr. Weiner focuses on diagnosing and treating spine and musculoskeletal pain as well as chronic migraines at the Spine and Wellness Centers of America. Her unique approach of personalized and preventative medicine focuses on empowering her patients to cultivate health using lifestyle and plant medicine. Her research focuses on using cannabis as a substitute for opioids in chronic pain patients and cannabis’ effect on seniors with chronic pain. Dr. Weiner is the Vice President of Mr. Psychedelic Law and on the Advisory Board for Iter Investments. She uses cannabis and ketamine-assisted psychotherapy as a catalyst to identify the root cause of one’s suffering, optimizing their quality of life.
Robinson is Founding Partner of Mr. Cannabis Law – a full service law firm focused on the cannabis and psychedelic industries; Co-Founder of Mr. Psychedelic Law – a non-profit focused on psychedelic legal reform; and Managing Principal of Iter Investments – a venture capital firm deploying capital across the psychedelic ecosystem.
When: Monday, Jan. 17, 2022; 7 p.m. EST
Where:
Soho Beach House Miami
4385 Collins Ave., Miami Beach, FL 33140
How: The event is private and only open to Soho Beach House members.
About Iter Investments:
Iter Investments is an investment firm that deploys capital in and around the burgeoning psychedelic industry. Iter Investments invests with the mission of re-imagining how the mental health and wellness industry delivers care. For more information, visit www.iterinvestments.com or email contact@iterinvestments.com.
About Mr. Psychedelic Law:
Mr. Psychedelic Law is a 501(c)(4) focused on using medical and spiritual research to drive responsible legal reform in Florida for psilocybin mushrooms and other entheogens. Mr. Psychedelic Law envisions a responsible legal framework that allows people to reach a higher level of consciousness through psilocybin mushrooms and other psychedelics while also accounting for the potential negative effects of taking these compounds under the wrong set and setting. For more information, visit www.mrpsychedeliclaw.com.
About Mr. Cannabis Law:
Mr. Cannabis Law is a full-service law firm focusing on the unique and highly regulated cannabis and psychedelic industries, from startups to established businesses. The firm stays abreast of all current legal developments and anticipates upcoming legal developments in the cannabis and psychedelic industries. It advises and consults in myriad areas of the industries, including licensing and registration, supply chain management, regulatory and tax compliance, real estate transactions, corporate formation and management structure, business litigation, business transactions, banking, accounting systems and reporting, quality control systems and reporting, research & development systems and reporting, inventory tracking and software implementation, manufacturing systems integration, and employment matters. The firm is located at 1000 SE 2nd St., Unit 6, Fort Lauderdale, FL 33301. For more information about Mr. Cannabis Law, visit mrcannabislaw.com, call 786-526-1155, or email info@mrcannabislaw.com.
